Nomination Committee appointed for the Annual General Meeting 2019
The Nomination Committee for the Annual General Meeting of Bactiguard Holding AB (publ), to be held on Wednesday 15 May 2019 at the company’s headoffice in Botkyrka, has been appoined.
The Nomination Committee for the 2019 AGM in Bactiguard Holding AB (publ) will consist of the following members:
Jan Ståhlberg, Chairman of the Board of Directors
Helena Borglund, appointed by KK Invest AB
Thomas von Koch, appointed by Bactiguard B.V.
Mats J Andersson, appointed by Nordea Fonder
Per Colleen, appointed by Fjärde AP Fonden
In accordance with the instructions for the Nomination Committee in Bactiguard Holding AB (publ), the Nomination Committee shall consist of five members. The chairman of the Board of Directors shall contact the four largest shareholders of the company, in terms of voting power, pursuant to Euroclear Sweden AB’s print out of the share register on 31 August. Each of the four largest shareholders shall be offered the opportunity to, within reasonable time, appoint a member who, together with the chairman of the Board, will constitute the Nomination Committee.
The Nomination Committee will make proposals to the AGM 2019 concerning
the election of a chairman for the AGM, the chairman and other members of the Board of Directors, as well as auditors. The Nomination Committee will also make proposals regarding remuneration to the Board of Directors, including any separate remuneration for committee work, as well as remuneration to the auditors. Further, the Nomination Committee will make a proposal regarding principles for forming the Nomination Committee for the AGM in 2020.
Shareholders who wish to make proposals to the Nomination Committee can do so by writing to the Nomination Committee under the following address:
Bactiguard Holding AB (publ)
146 21 Tullinge
Proposals can also be sent by email to the following address:
In order for the Nomination Committee to be able to address proposals in a constructive manner, they should have been received by 18 January, 2019.
The proposals of the Nomination Committee will be presented in the invitation to the AGM and at the company’s website.
For further information, please contact:
Cecilia Edström, CFO, cell phone: +46 722 262 328
Bactiguard is a Swedish medical device company with a mission to save lives. To achieve this mission we develop and supply infection protection solutions which reduce the risk of healthcare associated infections and the use of antibiotics. This way, we save significant costs for healthcare and the society at large. The Bactiguard technology prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard offers the technology through licence agreements and our BIP (Bactiguard Infection Protection) portfolio of products. Through our licence partner CR Bard, urinary catheters with Bactiguard’s coating are market leading in the USA and Japan. Bactiguard’s own product portfolio of urinary catheters, endotracheal tubes and central venous catheters prevent some of the most common infections, which appear in the urinary tract, the blood stream and the respiratory tract.
Bactiguard is in a strong expansion phase in the European markets, China, India and the Middle East as well by establishing license agreements in new therapeutic areas. The company has about 70 employees around the world. Its headquarters and one of two production facilities are located in Stockholm, the other one in Malaysia. Bactiguard is listed on Nasdaq Stockholm.
Read more about how Bactiguard saves lives on www.bactiguard.com